BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22566400)

  • 1. Prion-like spread of protein aggregates in neurodegeneration.
    Polymenidou M; Cleveland DW
    J Exp Med; 2012 May; 209(5):889-93. PubMed ID: 22566400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
    Goedert M; Falcon B; Clavaguera F; Tolnay M
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.
    Manca M; Kraus A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.
    Díaz-Nido J; Wandosell F; Avila J
    Peptides; 2002 Jul; 23(7):1323-32. PubMed ID: 12128089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative lesions: seeding and spreading.
    Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):825-33. PubMed ID: 24035591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration. Could they all be prion diseases?
    Miller G
    Science; 2009 Dec; 326(5958):1337-9. PubMed ID: 19965731
    [No Abstract]   [Full Text] [Related]  

  • 10. The prion protein in human neurodegenerative disorders.
    Kovacs GG; Zerbi P; Voigtländer T; Strohschneider M; Trabattoni G; Hainfellner JA; Budka H
    Neurosci Lett; 2002 Sep; 329(3):269-72. PubMed ID: 12183028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of crowded physiological environments in prion and prion-like protein aggregation.
    Ma Q; Hu JY; Chen J; Liang Y
    Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
    Goedert M; Masuda-Suzukake M; Falcon B
    Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
    Yan X; Uronen RL; Huttunen HJ
    Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.
    Jucker M; Walker LC
    Nature; 2013 Sep; 501(7465):45-51. PubMed ID: 24005412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading.
    Kundel F; Hong L; Falcon B; McEwan WA; Michaels TCT; Meisl G; Esteras N; Abramov AY; Knowles TJP; Goedert M; Klenerman D
    ACS Chem Neurosci; 2018 Jun; 9(6):1276-1282. PubMed ID: 29590529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.
    Saijo E; Groveman BR; Kraus A; Metrick M; Orrù CD; Hughson AG; Caughey B
    Methods Mol Biol; 2019; 1873():19-37. PubMed ID: 30341601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion-like features of misfolded Aβ and tau aggregates.
    Morales R; Callegari K; Soto C
    Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.